Compare BMRN & IT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | IT |
|---|---|---|
| Founded | 1996 | 1979 |
| Country | United States | United States |
| Employees | 3221 | 40 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.0B |
| IPO Year | 1999 | 2010 |
| Metric | BMRN | IT |
|---|---|---|
| Price | $55.48 | $148.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 9 |
| Target Price | $88.22 | ★ $216.63 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.80 | ★ 9.65 |
| Revenue | $1,313,646,000.00 | ★ $2,021,441,000.00 |
| Revenue This Year | $15.02 | $3.64 |
| Revenue Next Year | $12.23 | $5.12 |
| P/E Ratio | $30.52 | ★ $16.00 |
| Revenue Growth | ★ 17.62 | 13.30 |
| 52 Week Low | $50.76 | $139.18 |
| 52 Week High | $66.28 | $451.73 |
| Indicator | BMRN | IT |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 42.65 |
| Support Level | $51.77 | $142.32 |
| Resistance Level | $56.21 | $163.50 |
| Average True Range (ATR) | 1.36 | 7.14 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 41.16 | 34.30 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Gartner Inc delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization's mission-critical priorities. It delivers its products and services globally through three reportable segments - Business and Technology Insights, Conferences and Consulting. Insights equips executives and their teams from every Majority function, geography, industry and sector with actionable, objective insights, guidance and tools. Conferences provides executives and teams across an organization the opportunity to learn, share and network. and Consulting serves senior executives technology-driven strategic initiatives leveraging the power of Gartner's actionable, objective insight. The Majority revenue is derived from the Insights segment.